Search Results (25)
Click the Why column to see why an item matched the search.
Match | Type | Why |
---|
Current prescription of prophylactic factor infusions and perceived adherence for children and adolescents with haemophilia: a survey of haemophilia healthcare professionals in the United States. | Academic Article |
Why?
|
Using dried blood spots for variant analysis for patients with haemophilia. | Academic Article |
Why?
|
Anti-inhibitor coagulant complex prophylaxis in hemophilia with inhibitors. | Academic Article |
Why?
|
Trends in dedicated care for females with bleeding disorders within U.S. hemophilia treatment centers. | Academic Article |
Why?
|
Awareness, Care and Treatment In Obesity maNagement to inform Haemophilia Obesity Patient Empowerment (ACTION-TO-HOPE): Results of a survey of US patients with haemophilia and obesity (PwHO) and their partners and caregivers. | Academic Article |
Why?
|
A phase IV, multicentre, open-label study of emicizumab prophylaxis in people with haemophilia A with or without FVIII inhibitors undergoing minor surgical procedures. | Academic Article |
Why?
|
Increased prevalence of inhibitors in Hispanic patients with severe haemophilia A enrolled in the Universal Data Collection database. | Academic Article |
Why?
|
Prophylactic bypassing agent use before and during immune tolerance induction in patients with haemophilia A and inhibitors to FVIII. | Academic Article |
Why?
|
The development of pulmonary embolus in patients with haemophilia A and high-titre inhibitors - a case series and review of the literature. | Academic Article |
Why?
|
Health-related quality of life in patients with haemophilia and inhibitors on prophylaxis with anti-inhibitor complex concentrate: results from the Pro-FEIBA study | Academic Article |
Why?
|
A Prospective Observational Study of Antihemophilic Factor (Recombinant) Prophylaxis Related to Physical Activity Levels in Patients with Hemophilia A in the United States (SPACE). | Academic Article |
Why?
|
Individualized factor IX dosing in two brothers: application of longitudinal pharmacokinetic modelling to optimize therapeutic benefit. | Academic Article |
Why?
|
Novel treatment of combined factor V and factor VIII deficiency with Factor Eight Inhibitor Bypass Activity. | Academic Article |
Why?
|
Radionuclide synovectomy/synoviorthesis (RS) in patients with bleeding disorders: A review of patient and procedure demographics and functional outcomes in the ATHNdataset. | Academic Article |
Why?
|
Building the foundation for a community-generated national research blueprint for inherited bleeding disorders: facilitating research through infrastructure, workforce, resources and funding. | Academic Article |
Why?
|